Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(2.86)
# 1,763
Out of 4,711 analysts
185
Total ratings
26.56%
Success rate
3.42%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUMA Humacyte | Reiterates: Buy | $12 → $15 | $4.64 | +223.28% | 5 | Dec 20, 2024 | |
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $1.28 | +603.13% | 7 | Dec 18, 2024 | |
| CADL Candel Therapeutics | Reiterates: Buy | $11 → $19 | $8.75 | +117.14% | 5 | Dec 18, 2024 | |
| NVAX Novavax | Reiterates: Buy | $19 | $8.70 | +118.39% | 22 | Dec 10, 2024 | |
| ARTL Artelo Biosciences | Reiterates: Buy | $5 | $0.95 | +427.65% | 10 | Dec 9, 2024 | |
| WINT Windtree Therapeutics | Reiterates: Neutral | $7 | $0.32 | +2,086.13% | 2 | Dec 4, 2024 | |
| SAVA Cassava Sciences | Downgrades: Neutral | $116 | $2.35 | +4,836.17% | 22 | Nov 26, 2024 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $1.50 | +1,166.67% | 5 | Nov 25, 2024 | |
| ELDN Eledon Pharmaceuticals | Reiterates: Buy | $16 | $4.36 | +266.97% | 9 | Nov 20, 2024 | |
| GOVX GeoVax Labs | Reiterates: Buy | $8 | $2.29 | +249.34% | 14 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2 | $0.46 | +334.97% | 8 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $0.58 | +1,106.90% | 6 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.75 | +242.86% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $2.60 | +3,746.15% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.47 | +1,124.49% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $21 | $1.73 | +1,113.87% | 10 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $1.76 | +1,945.45% | 5 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $0.33 | +2,976.92% | 1 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $1.67 | +2,594.61% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $1.38 | +1,349.28% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $5.51 | +285,743.92% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.92 | +2,630.75% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $14.96 | +1,504.28% | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $0.74 | +10,712.27% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $0.69 | +14,401.16% | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $5.61 | +142,502.50% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $3.49 | +100.57% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $3.00 | +900.00% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $3.69 | +984.01% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $0.73 | +2,366.09% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.04 | +380.77% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,440 | $5.07 | +28,302.37% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $48.87 | -50.89% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $3.05 | +112,031.15% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $6.50 | +292,207.69% | 1 | Oct 6, 2017 |
Humacyte
Dec 20, 2024
Reiterates: Buy
Price Target: $12 → $15
Current: $4.64
Upside: +223.28%
Cardiol Therapeutics
Dec 18, 2024
Reiterates: Buy
Price Target: $9
Current: $1.28
Upside: +603.13%
Candel Therapeutics
Dec 18, 2024
Reiterates: Buy
Price Target: $11 → $19
Current: $8.75
Upside: +117.14%
Novavax
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $8.70
Upside: +118.39%
Artelo Biosciences
Dec 9, 2024
Reiterates: Buy
Price Target: $5
Current: $0.95
Upside: +427.65%
Windtree Therapeutics
Dec 4, 2024
Reiterates: Neutral
Price Target: $7
Current: $0.32
Upside: +2,086.13%
Cassava Sciences
Nov 26, 2024
Downgrades: Neutral
Price Target: $116
Current: $2.35
Upside: +4,836.17%
NRx Pharmaceuticals
Nov 25, 2024
Reiterates: Buy
Price Target: $19
Current: $1.50
Upside: +1,166.67%
Eledon Pharmaceuticals
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $4.36
Upside: +266.97%
GeoVax Labs
Nov 20, 2024
Reiterates: Buy
Price Target: $8
Current: $2.29
Upside: +249.34%
Nov 15, 2024
Reiterates: Buy
Price Target: $2
Current: $0.46
Upside: +334.97%
Nov 15, 2024
Reiterates: Buy
Price Target: $7
Current: $0.58
Upside: +1,106.90%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $1.75
Upside: +242.86%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $2.60
Upside: +3,746.15%
Nov 12, 2024
Reiterates: Buy
Price Target: $18
Current: $1.47
Upside: +1,124.49%
Aug 20, 2024
Reiterates: Buy
Price Target: $21
Current: $1.73
Upside: +1,113.87%
May 14, 2024
Reiterates: Buy
Price Target: $36
Current: $1.76
Upside: +1,945.45%
Jan 30, 2024
Initiates: Buy
Price Target: $10
Current: $0.33
Upside: +2,976.92%
Dec 14, 2023
Initiates: Buy
Price Target: $45
Current: $1.67
Upside: +2,594.61%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $1.38
Upside: +1,349.28%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $5.51
Upside: +285,743.92%
Mar 8, 2023
Reiterates: Buy
Price Target: $25
Current: $0.92
Upside: +2,630.75%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $14.96
Upside: +1,504.28%
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $0.74
Upside: +10,712.27%
Jun 30, 2021
Initiates: Buy
Price Target: $100
Current: $0.69
Upside: +14,401.16%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $5.61
Upside: +142,502.50%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $3.49
Upside: +100.57%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $3.00
Upside: +900.00%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $3.69
Upside: +984.01%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $0.73
Upside: +2,366.09%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $1.04
Upside: +380.77%
Oct 6, 2017
Initiates: Buy
Price Target: $1,440
Current: $5.07
Upside: +28,302.37%
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $48.87
Upside: -50.89%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $3.05
Upside: +112,031.15%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $6.50
Upside: +292,207.69%